CNS Anticancer Drug Discovery and Development Conference White Paper
Victor A. Levin(Orbus Therapeutics (United States)), Russell C. Petter(Texas Tech University), Jann N. Sarkaria(Mayo Clinic in Arizona), Timothy P. Heffron(Texas Tech University), Joohee Sul(United States Food and Drug Administration), Ramakrishna Samala(Texas Tech University), Patrick Y. Wen(Dana-Farber Cancer Institute), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Ted W. Johnson(WorldFish), Patrick J. Paddison(Sage Bionetworks), Forest M. White(Center for Cancer Research), Jean E. Lachowicz, James M. Gallo(Texas Tech University), Donald A. Berry(Berry & Associates (United States)), Antonio Iavarone(University of Miami), Marc R. Birtwistle(Clemson University), Shen Wang(Texas Tech University), Quentin R. Smith(Texas Tech University), William F. Elmquist(University of Minnesota), Peter J. Tonge(University of Rochester)
Cited by 45
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k